Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4004 participants
OBSERVATIONAL
2020-05-01
2020-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fear of Covid-19 Scale
The Fear of Covid-19 Scale (FCV-19S) is a questionnaire that evaluates fear of the global pandemic caused by the SARS-CoV-2. The FVC-19S consists of seven items, such as "It makes me uncomfortable to think about coronavirus-19," "I am afraid of losing my life because of coronavirus-19," and "When watching news and stories about coronavirus-19 on social media, I become nervous or anxious," each with a five-point Likert scale of options. The participant is instructed to choose the option that best represents their perception about the statement presented. The maximum possible total is 35 points. The scale's authors indicate that the higher the score is, the higher is the level of the participants' fear of COVID-19.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants over 15 years
Exclusion Criteria
* Participants with incomplete surveys
* Being a tourist currently staying in the country or being Mexican residing in another country
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto Mexicano del Seguro Social
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
GONZALEZ-OJEDA ALEJANDRO
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto Mexicano del Seguro Social
Guadalajara, Jalisco, Mexico
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ibarrola-Pena JC, Barbosa-Camacho FJ, Almanza-Mena YL, Chejfec-Ciociano JM, Reyes-Elizalde EA, Romero-Limon OM, Zaragoza-Organista R, Cervantes-Perez E, Sapien-Fernandez JH, Guzman-Barba JA, Flores-Becerril P, Ochoa-Rodriguez I, Najar-Hinojosa R, Cueto-Valadez AE, Cueto-Valadez TA, Lopez-Zendejas M, Fuentes-Orozco C, Cervantes-Guevara G, Miranda-Ackerman RC, Gonzalez-Ojeda A. Preventive measures against the COVID-19 pandemic in Mexico: A cross-sectional study. Front Public Health. 2022 Oct 11;10:932010. doi: 10.3389/fpubh.2022.932010. eCollection 2022.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Fear5
Identifier Type: -
Identifier Source: org_study_id